Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-23

Clinical Trial Update: Study to Confirm the AuthenTicity of Point of Care Urine samplEs Using Oral fluoreScein Sodium in adulTs With substancE Use Disorder (ATTESTED) [Phase 3]

View source ↗

Summary

Phase 3 study to confirm the authenticity of urine samples using oral fluorescein sodium in adults with substance use disorder; the trial is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluorescein Sodium (fluorescein sodium)

Snippet

Sponsor: UpTru Inc. | Conditions: Substance Use Disorder (SUD) | Phase 3 | Status: NOT_YET_RECRUITING